Source: LANCET HAEMATOLOGY. Unidade: FM
Subjects: ANEMIA FALCIFORME, HEMOGLOBINAS, MORTALIDADE
ABNT
THOMSON, Azalea M. et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. LANCET HAEMATOLOGY, v. 10, n. 8, p. E585-E599, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57873. Acesso em: 18 out. 2024.APA
Thomson, A. M., Mchugh, T. A., Oron, A. P., Teply, C., Lonberg, N., Tella, V. M. V., et al. (2023). Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. LANCET HAEMATOLOGY, 10( 8), E585-E599. doi:10.1016/S2352-3026(23)00118-7NLM
Thomson AM, Mchugh TA, Oron AP, Teply C, Lonberg N, Tella VMV, Wilner LB, Fuller K, Hagins H, Aboagye RG, Benseñor IJM. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 [Internet]. LANCET HAEMATOLOGY. 2023 ; 10( 8): E585-E599.[citado 2024 out. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57873Vancouver
Thomson AM, Mchugh TA, Oron AP, Teply C, Lonberg N, Tella VMV, Wilner LB, Fuller K, Hagins H, Aboagye RG, Benseñor IJM. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 [Internet]. LANCET HAEMATOLOGY. 2023 ; 10( 8): E585-E599.[citado 2024 out. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57873